Identifying and Demonstrating Product Value

Products pending FDA approval

• What attributes of your product will resonate with payers?

• How can you present the product to optimize payer response?

• How will it be positioned in a crowded market?

• What utilization management criteria can you expect?

Products in Phase 2 development

• Assuming similar results in Phase 3, what values will payers see in the product?

• Which patients constitute the likely target population?

• How can the Phase 3 trials highlight product value? Which secondary endpoints and other design features will best demonstrate value to payers, employers and their members?

Other services

• Custom projects and consultations

• Advisory boards

• Educational Presentations for Product, Market Access, HEOR, or Medical Science teams